| coordinators: | Marie-Claude Potier, France |
| |
Wednesday 21 September 2016
| 08:00 - 15:00
| Hall M2 |
| 08:00 - 09:30 | Down syndrome and other genetic developmental disorders: common mechanisms |
| |
| 08:00 - 08:30 | Neurodevelopmental disorders: mechanisms and boundary definitions from genomes, interactomes and proteomes |
| | speaker: | Victor Faundez, United States |
| |
| 08:30 - 09:00 | Fragile X syndrome: from molecular pathology to therapy |
| | speaker: | Barbara Bardoni, France |
| |
| 09:00 - 09:30 | New perspectives for the rescue of cognitive disability in Down syndrome |
| | speaker: | Renata Bartesaghi, Italy |
| |
| 10:15 - 11:45 | Challenges and opportunities for clinical trials |
| | chair: | Rafael de la Torre Fornell, Spain |
| |
| 10:15 - 10:45 | Recent advances in the pharmacology of neurodevelopmental disorders |
| | speaker: | Hanns Möhler, Switzerland |
| |
| 10:45 - 11:15 | Translating molecular advances in Down syndrome and in fragile X syndrome into therapy |
| | speaker: | Rafael de la Torre Fornell, Spain |
| |
| 11:15 - 11:45 | Computational methods to unravel the pathophysiology in Down syndrome |
| | speaker: | Mara Dierssen, Spain |
| |
| 13:00 - 14:30 | Down syndrome and other genetic developmental disorders: new avenues |
| |
| 13:00 - 13:30 | Boosting plasticity through neurorehablilitation with magnetic/electric stimulation and cognitive training |
| | speaker: | Roi Cohen Kadosh, United Kingdom |
| |
| 13:30 - 14:00 | Modelling Down syndrome in iPSCs |
| | speaker: | Dean Nizetic, Singapore |
| |
| 14:00 - 14:30 | Mouse models and development of DS therapeutics |
| | speaker: | Yann Herault, France |
| |
| 14:45 - 15:00 | General discussion and closing |